Westfield Capital Management CO LP Viking Therapeutics, Inc. Transaction History
Westfield Capital Management CO LP
- $21.2 Billion
- Q3 2024
A detailed history of Westfield Capital Management CO LP transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Westfield Capital Management CO LP holds 930,370 shares of VKTX stock, worth $36.6 Million. This represents 0.28% of its overall portfolio holdings.
Number of Shares
930,370
Previous 786,695
18.26%
Holding current value
$36.6 Million
Previous $41.7 Million
41.24%
% of portfolio
0.28%
Previous 0.21%
Shares
3 transactions
Others Institutions Holding VKTX
# of Institutions
475Shares Held
64.6MCall Options Held
5.72MPut Options Held
3.39M-
Vanguard Group Inc Valley Forge, PA10.2MShares$400 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$237 Million0.01% of portfolio
-
State Street Corp Boston, MA4.67MShares$184 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.12MShares$83.2 Million0.01% of portfolio
-
Morgan Stanley New York, NY1.87MShares$73.7 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $3.01B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...